Clinical Trial Update: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating veliparib in combination with radiation therapy in adults with advanced solid tumors featuring peritoneal carcinomatosis, including epi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Solid Neoplasm, Peritoneal Carcinomatosis | Phase 1 | Status: COMPLETED